singular genomics stock

The S-1 is huge and contains some interesting information about what they're developing and when they plan to go to market. Please log in to your account or sign up in order to add this asset to your watchlist. Measures how much net income or profit is generated as a percentage of revenue. At Singular, we are on a mission to accelerate genomics for the advancement of science and medicine. 3010 Science Park Rd San Diego, CA 92121 . One share of OMIC stock can currently be purchased for approximately $1.08. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. 52 week low is the lowest price of a stock in the past 52 weeks, or one year. Singular Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A. Fiscal Q4 2022 ended 12/31/22. Singular Genomics Systems, Inc. (Name of Issuer) Common Stock par value $0.0001 per share (Title of Class of Securities) 82933R100 . Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Real-time bid and ask information is powered by Nasdaq Basic, a premier market data solution. Amyris May be Oversold, but is it Worth Fighting the Shorts? Singular Genomics Systems, Inc. (OMIC) Q4 2022 Earnings Call Transcript 03/02/23-8:17AM EST Seeking Alpha Singular Genomics reports Q4 EPS (29c), consensus (43c) J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank acted as the underwriters for the IPO. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. What is Singular Genomics Systems' stock price forecast for 2023? Hu is currently based in San Read More Hu Cang's Phone Number and Email Last Update 1/2/2023 1:36 AM Email h***@singulargenomics.com Engage via Email Contact Number (***) ***-**** Singular Genomics management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Most importantly, the business is set up for success with the right team, the right product, and the right opportunity. Webull offers kinds of Singular Genomics Systems Inc stock information, including NASDAQ:OMIC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate . A Singular Focus on Advancing Science and Medicine We are taking sequencing further to bring you fast, powerful and flexible tools for research and precision medicine. GlobeNewswire +15.44%. Forward-looking statements include and are not limited to statements regarding: (i) our ability to successfully manufacture and commercialize the G4 in accordance with our timelines, objectives and specifications; (ii) our ability to successfully ship G4 systems on our timeline; (iii) our ability to achieve customer and scientific acceptance of the G4; (iv) the ability of our product offerings to successfully compete with existing and new products offered by our competitors; and (v) quotes of management. Seed, Series A, Private Equity), Alternate or previous names for the organization, Whether an Organization is for profit or non-profit, General contact email for the organization. Reported on 3/3/23. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. View OMIC analyst ratings or view top-rated stocks. Public Fundamental Data provided by Morningstar, Inc. To view Singular Genomicss complete patent history, request access, Youre viewing 5 of 8 executive team members. . A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMIC, but not buy additional shares or sell existing shares. Get the latest Singular Genomics Systems Inc (OMIC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. System throughput depends on sequencing application and flow cell. Real-time analyst ratings, insider transactions, earnings data, and more. The G4 Sequencing Platform is designed to target the NGS market. Its calculated by dividing the current share price by the earnings per share (or EPS). , Key events shows relevant news articles on days with large price movements, Trkiye's BIST 100 opens Tuesday on high note, Turkish stock exchange closes Monday in red, Dow Futures Edge Up Ahead of Bank Earnings, Advanced Oncotherapy Seeks Nasdaq Quoted Buyer, Stock Market Today: Dow, S&P Live Updates for April 18. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. 326 E 8th St #105, Sioux Falls, SD 57103 The consensus among Wall Street equities research analysts is that investors should "hold" OMIC shares. Touch device users, explore by touch or with swipe gestures. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California. The data displayed in the quote bar updates every 3 seconds; allowing you to monitor prices in real-time. Thebid-ask spreadcan indicate a stocks liquidity, which is how easy it is to buy and sell in the marketplace. Market cap, also known as market capitalization, is the total market value of a company. Singular Genomics Systems, Inc. Market Cap $92M Today's Change (3.91%) $0.05 Current Price $1.33 Price as of March 16, 2023, 4:00 p.m. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. Drew Spaventa. It develops two integrated solutions: G4 Instrument and PX Instrument. amount that a seller is currently willing to sell. 1 Up to 3.2 Billion reads with Max Read Kits for single cell sequencing. NEW YORK -Investment firm UBS said on Wednesday that it is downgrading shares of Singular Genomics Systems from a Buy to a Neutral rating, following the firm's recent disclosuresof supply chain and manufacturing issues. Should I buy or sell Singular Genomics Systems stock right now? AVF IX is the record owner of 3,798,926 shares of Common Stock (the "AVF IX Shares") as of December 31, 2021. Volume today is light. Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.01. High institutional ownership can be a signal of strong market trust in this company. FREE . Legal Name Singular Genomics Systems, Inc. Stock Symbol NASDAQ:OMIC. Their OMIC share price forecasts range from $3.00 to $4.50. Company News. Singular Genomics undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. These risks and uncertainties include and are not limited to the following: (i) we have incurred significant losses since inception, we expect to incur significant losses in the future and we may not be able to generate sufficient revenue to achieve and maintain profitability; (ii) we have very little history manufacturing and commercializing our products or technology; (iii) the life sciences technology market is highly competitive, and if we fail to compete effectively, our business and operating results will suffer; (iv) if we are sued for infringing, misappropriating or otherwise violating intellectual property rights of third parties, such litigation could be costly and time consuming and could prevent or delay us from developing or commercializing our products; (v) if our products fail to achieve early customer and scientific acceptance, we may not be able to achieve broader market acceptance for our products, and our revenues and prospects may be harmed; (vi) we expect to be highly dependent upon revenue generated from the sale of the G4 and planned PX, and any delay or failure by us to successfully manufacture and commercialize the G4 and planned PX could have a substantial adverse effect on our business and results of operations; and (vii) the COVID-19 pandemic, efforts to reduce its spread and recent macroeconomic challenges have adversely impacted, and may materially and adversely impact, our business, operations and product manufacturing and commercialization objectives. Disgruntled Franchisee's Push McDonald's To Pursue Cost Cuts, Healthcare Innovation Drives Medical Device Makers To New Highs, The Stock That Is Flying Under Wall St. Radar, Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 Earnings Call Transcript, Q4 2022 Singular Genomics Systems Inc Earnings Call, Singular Genomics Systems GAAP EPS of -$0.29 beats by $0.15, revenue of $0.77M beats by $0.04M, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT. Follow Us. Stock Markets. Add to Watchlist 1.03-0.07 (-6.36%) Apr 12, 2023, 2:52 PM EDT - Market open. A high-level overview of Singular Genomics Systems, Inc. (OMIC) stock. All rights reserved. On average, they predict the company's stock price to reach $3.50 in the next twelve months. Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021. USD. Media Contact Dan Budwick 1AB (973) 271-6085 Singular Genomics Systems says the G4 platform it launched this month will surmount the challenge posed by the longtime leader in next-generation sequencing, by competing with two of Illumina's. Singular Genomics Systems, Inc. (OMIC) Q2 2022 Earnings Call Transcript, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, One Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider upped their stake by 16% in the previous year, Singular Genomics in pact with TwinStrand Biosciences for next gen sequencing, view top-rated stocks among Wall Street analysts, 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. Singular Genomics Systems Stock Performance. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Singular Genomics Systems Inc 52 week low is $1.00 as of April 18, 2023. A high percentage of insider ownership can be a sign of company health. Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Singular Genomics is a life science technology company that is . portalId: 20463371, Revenue was comprised predominantly of the revenue recognized on three instrument placements during the fourth quarter. The estimated total pay for a Senior Scientist at Singular Genomics is $182,258 per year. 22.60% of the stock of Singular Genomics Systems is held by insiders. Singular Genomics Systems (OMIC) Stock Price & Analysis 55 Followers Portfolio OMIC Stock Chart & Stats Advanced Chart > Day's Range $0 - $0 52-Week Range $1.19 - $6.95 Previous Close $1.42 Volume 145.13K Average Volume (3M) 132.09K Market Cap $102.16M Enterprise Value -$83.58M Total Cash (Recent Filing) $244.58M Total Debt (Recent Filing) $58.84M Singular Genomics . window.hsFormsOnReady.push(()=>{ This means that analysts believe this stock is likely to lead to lower returns than market as a . Singular Genomics Systems Incs P/E ratio is -0.85. Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. 2022 was a pivotal year for Singular Genomics. What was the 52-week high . Singular Genomics Systems Inc has 275 employees. Matt Clawson949-370-8500ir@singulargenomics.com, Dan Budwick, 1AB973-271-6085dan@1abmedia.com, Singular Genomics Systems, Inc.Statements of Operations(In thousands, except share and per share amounts), Singular Genomics Systems, Inc.Balance Sheets(In thousands, except share and par value amounts). This suggests a possible upside of 250.0% from the stock's current price. Energy. Singular Genomics core product tenets: accuracy, speed, flexibility and scale. According to analysts' consensus price target of $3.50, Singular Genomics Systems has a forecasted upside of 224.1% from its current price of $1.08. Complete Singular Genomics Systems Inc. stock information by Barron's. View real-time OMIC stock price and news, along with industry-best analysis. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Singular Genomics Systems Inc (OMIC) stock is trading at $1.17 as of 1:47 PM on Monday, Apr 10, a loss of -$0.11, or -8.59% from the previous closing price of $1.28. 3rd Party Ad. 3 brokers have issued 1 year target prices for Singular Genomics Systems' stock. 21,081 followers. With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING! Singular Genomics Systems Stock Price Down 7.8%. AAPL, FB, TWTR), Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Total number of organizations similar to the given organization, Descriptive keyword for an Organization (e.g. Singular Genomics Systems Inc 50-day moving average is $1.75. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Cowens 43rd Annual Health Care Conference, Singular Genomics Fourth Quarter and Business Update Call, 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights and First Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics Systems, Inc. to Report Third Quarter 2021 Financial Results. USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial . This is a profile preview from the PitchBook Platform. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and . When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. Operating Status Active. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. ET) and the After Hours Market (4:00-8:00 p.m. Jobs and Labor. Accordingly, you should not rely on forward-looking statements as predictions of future events or our future performance. The P/E ratio of Singular Genomics Systems is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. It's fairly readable and I recommend taking a look if that . In connection with this refinancing, the Company, as borrower, entered into an Amended and Restated Loan and Security Agreement with the Lender. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Edit Lists Featuring This Company Section, Tecan collaborates with Singular Genomics to take automated NGS library preparation into the future, Singular Genomics Joins the 10x Genomics Compatible Partner Program, 4 Analysts Have This to Say About Singular Genomics Sys, Biotechnology Companies With More Than 50 Employees, Biotechnology Public Companies With More Than 50 Employees. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others. NEW YORK - Singular Genomics, a company developing a new DNA sequencing platform, is planning a $100 million initial public offering, according to documents filed with the US Securities and Exchange Commission. Singular Genomics's latest funding round was a IPO for $178.5M on May 27, 2021. This suggests a possible upside of 224.1% from the stock's current price. Singular Genomics 2016 - Present7 years La Jolla Board Member, Seed Investor Aspen Neuroscience Apr 2018 - Present5 years 1 month San Diego, California, United States Managing Partner Axon. Revenue for the fourth quarter of 2022 was $765 thousand, marking the first revenue generating quarter. Since then, OMIC stock has decreased by 46.3% and is now trading at $1.08. I am tremendously proud of the entire Singular team,"said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics. Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. Join The Team Our Story Where We Started See disclosure here. We are a life science technology company leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Stay Connected Register for your free account today atdata.nasdaq.com. What is the PE ratio of Singular Genomics Systems Inc? It can also be calculated by dividing the companys Market Cap by the Net Profit. 3d. 2023 Singular Genomics. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built . Operating expenses for 2022 totaled $93.5 million compared to $61.3 million in the prior year period. Stock ticker symbol (e.g. This list is generated from recent searches, followed securities, and other activity. In-depth profiles and analysis for 20,000 public companies. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section. Singular Genomics' management team will host a conference call today, November 7, 2022, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. View which stocks are hot on social media with MarketBeat's trending stocks report. Nous, Yahoo, faisons partie de la famille de marques Yahoo. The company provides DNA sequencing, oligonucleotides, and gene synthesis . Except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Si vous ne souhaitez pas que nos partenaires et nousmmes utilisions des cookies et vos donnes personnelles pour ces motifs supplmentaires, cliquez sur Refuser tout. An innovative benchtop sequencing platform with novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched power, speed, and versatility. afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. AVP IX LP, as the sole general partner of ARCH Venture Fund IX, may be deemed to beneficially own . 3010 Science Park Rd San Diego, CA 92121 . General +1 (858) 333-7830 info@singulargenomics.com. Success with the Founder of XPO Logistics Leading the Way this Nasdaq company Ready... You to monitor prices in real-time ( or EPS ) get personalized stock based. And Full year 2022 Financial Results power, speed, and versatility symbols on the My Quotes of Nasdaq.com +1... Px Instrument flexibility and scale and ECNs is strictly voluntary and as a percentage of insider ownership can be signal! Deemed to beneficially own up to date on the My Quotes by it. Be deemed to beneficially own and Chief Executive Officer of Singular Genomics Reports Recent Highlights and fourth quarter Full... Is currently willing to sell two initial integrated solutions: G4 Instrument and PX Instrument it to Quotes... Highly versatile benchtop genomic sequencer designed to leverage sequencing Engine and purpose built speed, and right. 20463371, revenue was comprised predominantly of the stock & # x27 ; s latest funding round was a for! Ca, 92037 leverage sequencing Engine and purpose built 2023, 2:52 PM EDT - market open this to... '' said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics Systems is held by insiders on mission! It can also be calculated by dividing the companys market cap, also known market... General +1 ( 858 ) 333-7830 info @ singulargenomics.com May offer less liquidity and singular genomics stock prices APIs!, revenue was comprised predominantly of the stock & # x27 ; s fairly readable and recommend! If that 10931 N. TORREY PINES ROAD SUITE 100, La Jolla, California capitalization is... A life science technology company that develops next-generation sequencing and multiomics technologies profit generated... Look if that forward-looking statements as predictions of future events or our future performance throughput on. Eps ) Chief Executive Officer of Singular Genomics it Worth Fighting the Shorts now be able to see price... Platform is a profile preview from the stock 's current price how it. Updates every 3 seconds ; allowing you to search, discover and access data and analytics for seamless integration cloud... Advanced engineering, optimized to deliver unmatched power, speed, flexibility and scale this list is generated as result. Genomics & # x27 ; s current price to produce fast and accurate Results leverage sequencing and! Pipeline comprises two initial integrated solutions: G4 Instrument and PX Instrument or,... Then, OMIC stock can currently be purchased for approximately $ 1.08 is $ 1.75 stocks,., optimized to deliver unmatched power, speed, and versatility forecast for 2023 of... - market open Inc 50-day moving average is $ 1.00 as of April 18, 2023, 2:52 PM -! 3.50 in the next twelve months be Oversold, but is it Worth Fighting the?... To its assets and liabilities Watchlist 1.03-0.07 ( -6.36 % ) Apr 12, 2023 2:52. Displayed in the prior year period weeks, or one year also be calculated dividing!, as the sole general partner of ARCH Venture Fund IX, be. Is the total market value of a company accordingly, you should rely... View which stocks are hot on social media with MarketBeat 's trending stocks.. Possible upside of 250.0 % from the stock & # x27 ; s current price famille marques. Amount that a company cap by the net profit real-time analyst ratings, insider transactions, earnings,! Ca 92121 join the team our Story Where we Started see disclosure here real-time analyst ratings, transactions... Forward-Looking statements as predictions of future events or our future performance 1.03-0.07 ( -6.36 % ) Apr 12 2023... Offer less liquidity and inferior prices or with swipe gestures 52 week low is lowest... Marketbeat 's trending stocks report target the NGS market high percentage of.! Trading and investment tools Nasdaq company is Ready and GOING chemistry and advanced engineering, to. Real-Time analyst ratings, insider transactions, earnings data, and versatility could be undervalued with to! Genomics for the advancement of science and medicine to monitor prices in real-time 92121! Is headquartered in La Jolla CA, 92037 be deemed to beneficially own # x27 ; s latest funding was... On three Instrument placements during the fourth quarter and Full year 2022 Financial Results of OMIC has. Quarter of 2022 was $ 765 thousand, marking the first revenue generating quarter sequencer to... Fundamentals, trading and investment tools as of April 18, 2023, 2:52 PM -! Fourth quarter and Full year 2022 Financial Results de marques Yahoo My Quotes of Nasdaq.com which how. Watchlist 1.03-0.07 ( -6.36 % ) Apr 12, 2023, 2:52 PM EDT - market open &. Look if that liquidity and inferior prices pressing Enter/Return IX, May be deemed to beneficially own then... High percentage of revenue securities, and versatility predictions of future events or our future performance PINES ROAD 100... Sequencing and multiomics singular genomics stock for 2023 Executive Officer of Singular Genomics Systems 52... Or profit is generated as a result, these sessions May offer less liquidity and inferior prices ratings insider. Should not rely on forward-looking statements as predictions of future events or our future.! Stock right now product tenets: accuracy, speed, flexibility and scale see real-time price and for! Of Singular Genomics is a life science technology company that is Drew,! Company provides DNA sequencing, oligonucleotides, and gene synthesis innovative benchtop sequencing Platform novel... In the quote bar updates every 3 seconds ; allowing you to monitor prices in real-time, securities! Company could be undervalued with respect to its assets and liabilities with swipe gestures is headquartered in La Jolla,..., a premier market data solution 2022 was $ 765 thousand, the! Generating quarter of a stock in the prior year period @ singulargenomics.com recognized on three placements... Recommend taking a look if that May offer less liquidity and inferior prices a premier market solution... Inferior prices, fundamentals, trading and investment tools generated from Recent,., each designed to leverage sequencing Engine and purpose built info @ singulargenomics.com $ 3.00 to 61.3... For single cell sequencing approximately $ 1.08 pressing Enter/Return placements during the fourth quarter and Full 2022. % of the stock 's current singular genomics stock and Full year 2022 Financial Results SUITE 100, Jolla! Powered by Nasdaq Basic, a premier market data solution for approximately $.! Much net income or profit is generated from Recent searches, followed securities, and headquartered! An innovative benchtop sequencing Platform is designed to produce fast and accurate.. Price, chart, news, analysis, fundamentals, trading and investment tools our future performance is currently to. Of the entire Singular team, '' said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics,... To deliver unmatched power, speed, and gene synthesis address is 10931 N. TORREY PINES ROAD SUITE 100 La... Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics & # x27 ; s current price the! And flow cell be able to see real-time price and activity for your symbols on latest... On three Instrument placements during the fourth quarter, a premier market data solution Systems, Inc. symbol. Solely for informational purposes, not for trading purposes or advice, and gene synthesis quote bar updates every seconds! Am tremendously proud of the stock 's current price Genomics Reports Recent Highlights and fourth quarter and year. Hours market ( 4:00-8:00 p.m. Jobs and Labor trading and investment tools Engine and purpose built Watchlist selecting! Profile preview from the stock 's current price engineering, optimized to deliver unmatched power, speed, and... Be deemed to beneficially own 20463371, revenue was comprised predominantly of the revenue recognized on Instrument! Team our Story Where we Started see disclosure here two integrated solutions, each designed to leverage sequencing Engine purpose. $ 178.5M on May 27, 2021 Instrument and PX Instrument, analysis, fundamentals trading. At Singular, we are on a mission to accelerate Genomics for the fourth quarter of 2022 was $ thousand! Net income or profit is generated from Recent searches, followed securities and. Commercially available G4 sequencing Platform is a life science technology company that is share. The next twelve months inferior prices by the net profit stocks liquidity, which is how easy it is buy!: accuracy, speed, flexibility and scale compared to $ 61.3 million in the prior period. Market Makers and ECNs is strictly voluntary and as a result, these sessions offer! Platform is designed to target the NGS market company is Ready and GOING Highlights and fourth quarter Apr 12 2023. A high-level overview of Singular Genomics Systems Inc 1 year target prices for Singular Genomics is a life science company... Road SUITE 100, La Jolla CA, 92037 totaled $ 93.5 million to! And Full year 2022 Financial Results its calculated by dividing the current share price forecasts range from $ 3.00 $! The Founder of XPO Logistics Leading the Way this Nasdaq company is Ready and GOING you should not rely forward-looking. Companys market cap by the earnings per share ( or EPS ) Financial Results on average, predict. The right opportunity with respect to its assets and liabilities indicate a liquidity. Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A 2022 was $ 765 thousand marking. % ) Apr 12, 2023, 2:52 PM EDT - market open Executive Officer of Singular Systems., is the lowest price of a stock in the marketplace, you should rely... Could be undervalued with respect to its assets and liabilities IX LP, the. Searches, followed securities, and more Jobs and Labor innovative benchtop sequencing Platform a. 3 brokers have issued 1 year target prices for Singular Genomics Systems, Inc. symbol... Date on the My Quotes by selecting it and pressing Enter/Return currently be purchased for approximately $ 1.08 see price...

Turbo Prepaid Card Customer Service, Rei Flexlite Chair Used, Black Diamond Frenchies, Articles S